The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside experts.

The FDA has introduced Elsa, an internal AI tool to review safety data, identify labeling issues, and prioritize inspections, ...

On June 2, 2025, FDA announced the launch of Elsa, a generative AI tool designed to “help employees—from scientific reviewers to investigators—work more efficiently.” Per FDA, the tool ...

The U.S. Food and Drug Administration (FDA) has introduced “Elsa,” a generative AI tool designed to enhance the efficiency of its regulatory operations. Elsa's deployment comes nearly a month ...

FDA Will Use AI to Approve Drugs and Devices Faster The agency launched a large-language model, dubbed Elsa, just last week to streamline operations.

One of the concerns people have when they hear FDA is using AI in the drug approval process is that many people don't have a ...

It said Elsa is a large language model-powered AI tool built within a “high-security GovCloud environment.” The FDA said the tool will assist with reading, writing and summarizing information.

Welcome to the inaugural issue of the Food Exec Brief — our new weekly roundup of key headlines for food manufacturing ...

The Trump Administration is bringing prior authorizations (PAs), the mandatory preapproval before insurance covers health ...

The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving efficiency across its operations, including scientific reviews.

Some FDA staff said Elsa often gave wrong answers, what experts call “hallucinations”, and has to be double-checked.